Spero Therapeutics (SPRO) EBT Margin Growth (1y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -2,817.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,558.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -683.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 2,688.00 |
| 10 | Spero Therapeutics | 162.39 Mn | 106.26 Mn | - | -255,540.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -255,540.00 |
| Dec 31, 2025 | -35,192.00 |
| Sep 30, 2025 | 2.67 Mn |
| Jun 30, 2025 | 29,060.00 |
| Mar 31, 2025 | -9,951.00 |
| Dec 31, 2024 | -16,520.00 |
| Sep 30, 2024 | -2.63 Mn |
| Jun 30, 2024 | 13,583.00 |
| Mar 31, 2024 | 581,142.00 |
| Dec 31, 2023 | -7,918.00 |
| Sep 30, 2023 | 12,026.00 |
| Jun 30, 2023 | 86,457.00 |
| Mar 31, 2023 | -449,148.00 |
| Dec 31, 2022 | 34,146.00 |
| Sep 30, 2022 | 259,701.00 |
| Jun 30, 2022 | -42,647.00 |
| Mar 31, 2022 | -119,205.00 |
| Sep 30, 2021 | 4.68 Mn |
| Jun 30, 2021 | 18,831.00 |
| Mar 31, 2021 | 106,324.00 |
| Sep 30, 2020 | -4.96 Mn |
| Jun 30, 2020 | 1.88 Mn |
| Mar 31, 2020 | -125,698.00 |
| Dec 31, 2019 | -304,389.00 |
| Sep 30, 2019 | 121,144.00 |
| Jun 30, 2019 | -1.77 Mn |
| Dec 31, 2018 | 76,701.00 |
| Sep 30, 2018 | 5,845.00 |
| Jun 30, 2018 | 191,112.00 |
| Dec 31, 2017 | -1.49 Mn |
| Sep 30, 2017 | 626,542.00 |